Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.53 |
| ▸ | GAA | P10253 | 2/20 | 0.53 |
| ▸ | MAPT | P10636 | 1/20 | 0.53 |
| ▸ | TTR | P02766 | 1/20 | 0.46 |
| ▸ | HTR3E | A5X5Y0 | 1/20 | 0.44 |
| ▸ | HTR3B | O95264 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | THPO | P40225 | 1/20 | 0.44 |
| ▸ | HTR3A | P46098 | 1/20 | 0.44 |
| ▸ | HTR3D | Q70Z44 | 1/20 | 0.44 |
| ▸ | HTR3C | Q8WXA8 | 1/20 | 0.44 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30663244 | 0.90 | ALDH1A1 (0.54) | ALDH1A1KDM4EGAAMAPTDYRK1A | |
| SCHEMBL29024921 | 0.82 | MAPT (0.60) | ALDH1A1MAPTPOLBLMNANPSR1 | |
| SCHEMBL8541741 | 0.82 | ALDH1A1 (0.58) | ALDH1A1KDM4EGAAMAPTTTR | |
| SCHEMBL28006558 | 0.81 | ALDH1A1 (0.50) | ALDH1A1KDM4EGAAMAPTTTR | |
| SCHEMBL2906892 | 0.80 | ALDH1A1 (0.60) | ALDH1A1DYRK1APOLBKMT2AMEN1 | |
| SCHEMBL8539149 | 0.79 | ALDH1A1 (0.53) | ALDH1A1KDM4EGAAMAPTTTR | |
| SCHEMBL1202391 | 0.79 | LCK (0.50) | ALDH1A1KDM4EGAAMAPTCYP1A2 | |
| SCHEMBL5214685 | 0.79 | ALDH1A1 (0.58) | ALDH1A1MAPTPOLBKMT2AMEN1 | |
| SCHEMBL5990759 | 0.79 | ALDH1A1 (0.58) | ALDH1A1CYP3A4POLBKMT2AMEN1 | |
| SCHEMBL2902589 | 0.78 | ALDH1A1 (0.51) | ALDH1A1KDM4EGAAMAPTCYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114213394-B | Synthesis method of N-sugar analysis reagent fluorogenic substrate | 上海瀚诺威生物科技有限公司 | 2022-11-08 | — | — | CN | claimed |
| CN-114213394-A | Synthesis method of N-sugar analysis reagent fluorogenic substrate | 上海瀚诺威生物科技有限公司 | 2022-03-22 | — | — | CN | claimed |
| CN-114213394-B | Synthesis method of N-sugar analysis reagent fluorogenic substrate | 上海瀚诺威生物科技有限公司 | 2022-11-08 | — | — | CN | disclosed |
| CN-114213394-A | Synthesis method of N-sugar analysis reagent fluorogenic substrate | 上海瀚诺威生物科技有限公司 | 2022-03-22 | — | — | CN | disclosed |
| CN-1142162-C | Bicyclic oxazolidinones as antibacterial agents | �������Ŷ���Լ��������˾ | 2004-03-17 | — | — | CN | disclosed |
| EP-1181288-B1 | BICYCLIC OXAZOLIDINONES AS ANTIBACTERIAL AGENT | UPJOHN CO (US) | 2003-07-30 | — | — | EP | disclosed |
| US-20020143009-A1 | Novel bicyclic oxazolidinones as antibacterial agents | PHARMACIA & UPJOHN | 2002-10-03 | — | — | US | disclosed |
| CN-1353709-A | Bicyclic oxazolidinones as antibacterial agents | PHARMACIA & UP JOHN CO (US) | 2002-06-12 | — | — | CN | disclosed |
| US-6387896-B1 | GRAMNEGATIVE, GRAMPOSITVE BACTERIA | PHARMACIA & UPJOHN CO. | 2002-05-14 | — | — | US | disclosed |
| EP-1181288-A1 | BICYCLIC OXAZOLIDINONES AS ANTIBACTERIAL AGENT | PHARMACIA & UPJOHN COMPANY (US) | 2002-02-27 | — | — | EP | disclosed |
| WO-2000073301-A1 | BICYCLIC OXAZOLIDINONES AS ANTIBACTERIAL AGENT | PHARMACIA & UPJOHN COMPANY (US) | 2000-12-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020143009-A1 | Novel bicyclic oxazolidinones as antibacterial agents | OXA1L, MRPL21, RPS4Y1 | ALDH1A1 1430/4885KDM4E 3964/4885GAA 1690/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.